Eric Zhang Selected Research

Eric Zhang Research Topics

Disease

6	Myocardial Infarction 04/2024 - 01/2019
6	Neoplasms (Cancer) 08/2021 - 11/2011
4	Pain (Aches) 01/2023 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 06/2020
2	Stroke (Strokes) 01/2020 - 08/2015
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Nausea 01/2023
1	Vomiting 01/2023
1	Blindness (Hysterical Blindness) 01/2023
1	Inflammation (Inflammations) 10/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Phenylketonurias (Phenylketonuria) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	COVID-19 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Heart Failure 01/2021
1	Hypertrophy 01/2021
1	Insulin Resistance 01/2021
1	Weight Gain 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Vascular Remodeling 12/2019
1	Hyperplasia 12/2019
1	Neointima 12/2019
1	Glioma (Gliomas) 05/2019
1	Cognitive Dysfunction 05/2019
1	Infarction (Infarctions) 12/2018
1	Chronic Pain 01/2018
1	Fatty Liver 01/2017
1	Adenocarcinoma 07/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016
1	Non-alcoholic Fatty Liver Disease 11/2015
1	Fibrosis (Cirrhosis) 11/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2011
1	Glaucoma 11/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2011
2	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
1	Carbofuran (Furadan)IBA 01/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	Inositol (Myoinositol)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 01/2022
1	Local AnestheticsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Trypan Blue FDA Link 01/2022
1	BromidesIBA 01/2022
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	LipidsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	romidepsin (FK228)FDA Link 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	CytokinesIBA 12/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2018
1	Ketamine FDA LinkGeneric 01/2018
1	Methionine (L-Methionine)FDA Link 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	BMS 754807IBA 07/2016
1	130-nm albumin-bound paclitaxelIBA 07/2016
1	Insulin-Like PeptidesIBA 07/2016
1	Keratins (Keratin)IBA 11/2015
1	Transient Receptor Potential ChannelsIBA 08/2015
1	Phosphotransferases (Kinase)IBA 05/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2011
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 11/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2011
1	Gefitinib (Iressa)FDA Link 11/2011
1	ProstaglandinsIBA 11/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 11/2011
1	Percutaneous Coronary Intervention 04/2024
1	Pain Management 08/2021
1	Art Therapy 01/2021
1	Immunotherapy 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Lasers (Laser) 01/2020
1	Transplantation 12/2019
1	Craniotomy 05/2019
1	Analgesia 05/2019